94 Effects of chemoimmunotherapy on the peripheral blood: insights from immune monitoring of a phase Ib trial of pembrolizumab and paclitaxel or capecitabine for triple-negative breast cancer (TNBC)

Brie Chun; Joanna Pucilowska; Shu Ching Chang; Isaac Kim; Benjamin Nikitin; Yoshinobu Koguchi; William Redmond; Brady Bernard; Venkatesh Rajamanickam; Nathan Polaske; Paul Fields; Valerie Conrad; Mark Schmidt; Walter Urba; Alison Conlin; Heather McArthur; David Page

doi:10.1136/jitc-2021-SITC2021.094

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Alerts

PDF

Regular and Young Investigator Award Abstracts

Biomarkers, Immune Monitoring, and Novel Technologies

94 Effects of chemoimmunotherapy on the peripheral blood: insights from immune monitoring of a phase Ib trial of pembrolizumab and paclitaxel or capecitabine for triple-negative breast cancer (TNBC)

Free

Log in using your username and password

Main menu

Log in using your username and password

You are here

Read the full text or download the PDF:

Log in using your username and password